The term α-neurotoxin was coined by C.C. Chang, who designated the postsynaptic bungarotoxin with the α- prefix because it happened to be slowest moving of the bungarotoxins under starch zone electrophoresis. The "α-" prefix subsequently came to connote any toxins with postsynaptic action. Members of this group are sometimes referred to as "curaremimetics" due to the similarity of their effects with the plant alkaloidcurare.
As more snake venoms were characterized, many were found to contain homologous nAChR-antagonist proteins. These came to be collectively known as the snake venom α-neurotoxins.
All α-neurotoxins share the three-finger toxintertiary structure, consisting of a small globular core containing four disulfide bonds, three loops or "fingers", and a C-terminal tail.
The class can be divided into two groups distinguished by length; short-chain neurotoxins have 60-62 residues and only the four core disulfide bonds characteristic of the fold, while long-chain neurotoxins have 66 or more residues, often including a longer C-terminus, and an additional disulfide bond in the second "finger" loop. These classes have significant sequence homology and share the same three-dimensional structure, but have differing specificities and kinetics of association/dissociation with the receptor. Localized mobility at the tips of fingers I and II is essential for binding. Accordingly, mutation of these residues produces large effects on binding. The additional disulfide bond in the second loop of the long-chain forms is likewise thought to influence binding specificity. Although both short and long-chain neurotoxins bind the same site on their target receptors, short-chain neurotoxins do not potently block α7 homo-oligomeric neuronal AChRs, while long-chain neurotoxins do.α-bungarotoxin and α-cobratoxin are both long-type.
α-Neurotoxins antagonistically bind tightly and noncovalently to nAChRs of skeletal muscles, thereby blocking the action of ACh at the postsynaptic membrane, inhibiting ion flow and leading to paralysis. nAChRs contain two binding sites for snake venom neurotoxins. Some computational studies of the mechanism of inhibition using normal mode dynamics suggest that a twist-like motion caused by ACh binding may be responsible for pore opening, and that this motion is inhibited by toxin binding.
Although three-finger protein domains are widespread, three-finger toxins appear only in snakes, and are particularly enriched in elapids. There is evidence that alpha-neurotoxins have evolved rapidly and are subject to positive selection, possibly due to an evolutionary arms race with prey species.
^Zeng H, Moise L, Grant MA, Hawrot E (June 2001). "The solution structure of the complex formed between alpha-bungarotoxin and an 18-mer cognate peptide derived from the alpha 1 subunit of the nicotinic acetylcholine receptor from Torpedo californica". The Journal of Biological Chemistry. 276 (25): 22930–40. doi:10.1074/jbc.M102300200. PMID11312275.
^ abcMoise L, Piserchio A, Basus VJ, Hawrot E (April 2002). "NMR structural analysis of alpha-bungarotoxin and its complex with the principal alpha-neurotoxin-binding sequence on the alpha 7 subunit of a neuronal nicotinic acetylcholine receptor". The Journal of Biological Chemistry. 277 (14): 12406–17. doi:10.1074/jbc.M110320200. PMID11790782.
^Connolly PJ, Stern AS, Hoch JC (January 1996). "Solution structure of LSIII, a long neurotoxin from the venom of Laticauda semifasciata". Biochemistry. 35 (2): 418–26. doi:10.1021/bi9520287. PMID8555211.
^Trémeau O, Lemaire C, Drevet P, Pinkasfeld S, Ducancel F, Boulain JC, Ménez A (April 1995). "Genetic engineering of snake toxins. The functional site of Erabutoxin a, as delineated by site-directed mutagenesis, includes variant residues". The Journal of Biological Chemistry. 270 (16): 9362–9. doi:10.1074/jbc.270.16.9362. PMID7721859.
^de la Rosa G, Corrales-García LL, Rodriguez-Ruiz X, López-Vera E, Corzo G (July 2018). "Short-chain consensus alpha-neurotoxin: a synthetic 60-mer peptide with generic traits and enhanced immunogenic properties". Amino Acids. 50 (7): 885–895. doi:10.1007/s00726-018-2556-0. PMID29626299.
^ abLevitt M, Sander C, Stern PS (February 1985). "Protein normal-mode dynamics: trypsin inhibitor, crambin, ribonuclease and lysozyme". Journal of Molecular Biology. 181 (3): 423–47. doi:10.1016/0022-2836(85)90230-X. PMID2580101.
^Kessler P, Marchot P, Silva M, Servent D (August 2017). "The three-finger toxin fold: a multifunctional structural scaffold able to modulate cholinergic functions". Journal of Neurochemistry. 142 Suppl 2: 7–18. doi:10.1111/jnc.13975. PMID28326549.
^Casewell NR, Wüster W, Vonk FJ, Harrison RA, Fry BG (April 2013). "Complex cocktails: the evolutionary novelty of venoms". Trends in Ecology & Evolution. 28 (4): 219–29. doi:10.1016/j.tree.2012.10.020. PMID23219381.